Company: CRESW
Filing Date: 2025-10-31
Form Type: 6-K
Source: 0001034957-25-000019
Chunk: 6

Company: CRESUD INC
Filing Date: 2025-10-31
Form: 6-K
Chunk 6
---
, THROUGH THE DELIVERY OF SHARES FOR THE DIFFERENTIAL AMOUNT BETWEEN THE EXERCISE VALUE WITH CASH PAYMENT AND THE EQUIVALENT MARKET VALUE. DELEGATION TO THE BOARD OF DIRECTORS FOR ITS IMPLEMENTATION WITH THE BROADEST POWERS.

It was resolved, by majority vote, to approve: (i) the execution of an addendum to the Warrant Agreement introducing the cashless exercise alternative (except for the payment of the par value of the shares), that is, allowing the delivery of shares for an amount equal to the difference between the exercise price of such options with cash payment and the equivalent market value of the shares, net of the payment of their par value. The purpose of this amendment is to include an additional exercise alternative for the warrant holders, under which no cash payment is required (except for the payment of the par value of the shares). This alternative implies a lower number of shares to be issued by the Company if investors choose to exercise their options in this manner, thus resulting in less dilution for the other shareholders of the Company due to the exercise of such options under this modality. It is expressly stated that the inclusion of the cashless exercise alternative (except for the payment of the par value of the shares) does not affect the right of the beneficiaries to exercise their options through the other methods provided for in the Warrant Agreement but rather is added as an additional alternative. It is also recorded that the proposed modality does not affect the economic rights of the other shareholders. This alternative also avoids an increased trading volume and fluctuations in the prices of the Company’s warrants and shares that could otherwise arise from arbitrage opportunities or share sales made to fund the exercise of options, which might negatively affect their market quotations; and (ii) to delegate to the Board of Directors of the Company and/or to such persons as it may designate, the implementation of the necessary amendments to the Warrant Agreement, the establishment of the terms for the exercise of the options under this modality, the determination of the exercise methodology based on market conditions, and the execution of all actions, negotiations, and/or the setting of any other terms and conditions that may be necessary or advisable for the implementation of the proposed process.

FOURTEENTH ITEM: CONSIDERATION OF THE DISTRIBUTION OF UP TO 5,300,000 (FIVE MILLION THREE HUNDRED THOUSAND) OWN SHARES TO THE SHAREHOLDERS IN PROPORTION TO THEIR HOLDINGS PURSUANT TO THE PROVISIONS